About
About Shionogi
Who we are
Heritage
Global affiliates and locations
Shionogi BV - tax strategy
Transparency
Investor Relations
Grants and Donations
Sustainability
Innovation
Innovation
Our areas of focus
Our Partners
Drug Discovery
Antimicrobial Resistance
News
Investors
Careers
Contact
Europe
Worldwide
HOME
News
2023
09
Investigational Treatment for Fragile X Syndrome Receives Rare Pediatric Disease Designation
Release
Medical News
2023/09/27
Investigational Treatment for Fragile X Syndrome, Receives Rare Pediatric Disease Designation from the U.S. FDA